Evidence map›Paper›PMID 34285702›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Transcriptomic Analysis Exploring the Molecular Mechanisms of Hanchuan Zupa Granules in Alleviating Asthma in Rat.

Hailong Yin, Yanbo Fan, Dandan Mu, Fei Song, Fang Tian, Qiang Yin

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hailong YinResearch and Development Department, Xinjiang Uygur Pharmaceutical Co., Ltd., Wulumuqi, Xinjiang 830001, China.ORCID https://orcid.org/0000-0001-5319-0651
Yanbo FanScience and Education Department, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430014, China.ORCID https://orcid.org/0000-0001-7357-2040
Dandan MuResearch and Development Department, Xinjiang Uygur Pharmaceutical Co., Ltd., Wulumuqi, Xinjiang 830001, China.ORCID https://orcid.org/0000-0002-2474-0746
Fei SongResearch and Development Department, Xinjiang Uygur Pharmaceutical Co., Ltd., Wulumuqi, Xinjiang 830001, China.ORCID https://orcid.org/0000-0002-3036-2219
Fang TianResearch and Development Department, Xinjiang Uygur Pharmaceutical Co., Ltd., Wulumuqi, Xinjiang 830001, China.ORCID https://orcid.org/0000-0001-5059-6461
Qiang YinDepartment of Management, Xinjiang Uygur Pharmaceutical Co., Ltd., Wulumuqi, Xinjiang 830001, China.ORCID https://orcid.org/0000-0001-7411-0147
Xinjiang Uygur Autonomous Region Uygur Medicine Hospital · CNWuhan City Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the molecular mechanisms of HCZP treatment of asthma. MATERIALS AND

methodsThirty Sprague Dawley (SD) rats were divided into normal, asthma, and HCZP groups (

resultsInflammatory cell infiltration and pathological damage of the lungs improved in the HCZP group. Compared with the asthma group (0.049 ± 0.002 mm

Identifiers

PMID34285702
PMCPMC8275397
OpenAlexW3182518366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.